GPT Analysis
Empower Your Investments! Unleash the Potential with Smart Stock Analysis!
Symbol | Company Name | Rating | Recommendation | Evaluation from GPT | Action | Time |
---|---|---|---|---|---|---|
TSM | Taiwan Semiconductor Manufacturing | None | None | None | | 2025-01-17 19:29:12 |
VALN | Valneva SE | None | None | None | | 2025-01-17 19:02:56 |
MTTR | Matterport Inc - Class A | None | None | None | | 2025-01-17 03:01:32 |
BX | Blackstone Inc | None | None | None | | 2025-01-16 21:15:13 |
GE | General Electric Company | None | None | None | | 2025-01-16 21:14:03 |
AAPL | Apple Inc | None | None | None | | 2025-01-15 19:16:28 |
ASML | ASML Holding NV | None | None | None | | 2025-01-15 14:48:40 |
SAP | Sap SE | None | None | None | | 2025-01-15 14:45:56 |
NVDA | NVIDIA Corp | 85 | Positive | NVIDIA Corp (NVDA) is a well-established company in the technology sector, specializing in the design and manufacture of high-performance graphics processing units (GPUs). The company has shown consistent growth over the years, with a | | 2025-01-13 14:36:45 |
HD | Home Depot Inc | 75 | Positive | Home Depot Inc (HD) is a well-established company in the retail sector. The company has a strong market position and a solid financial performance. HD has shown consistent growth in its revenue and earnings over the years. It has a large market capitalization, indicating its stability and ability to withstand market fluctuations. However, the stock is currently trading below its 50-day average, indicating a short-term downtrend. While the year-to-date performance has been | | 2025-01-11 17:43:35 |
HCA | HCA Healthcare Inc | 70 | Neutral | HCA Healthcare Inc (HCA) is a leading provider of healthcare services in the United States. The stock has shown a year-to-date return of 7.3%, which is above average compared to the overall market performance. However, the stock has experienced a decline from its year high of $417.14 to its current price of $302.82, suggesting some weakness. The stock's 200-day moving average of $345.37 is also above its current price, indicating a potential downtrend. With a market capitalization of $78.8 billion, HCA is a large-cap company with a strong presence in the healthcare industry. While the stock has shown some volatility, it still has long-term growth potential. Therefore, considering the current market conditions and the stock's performance, the sentiment is neutral. The rating for HCA would be 70, indicating a moderate investment potential. | | 2025-01-11 17:33:01 |
LLY | Lilly(Eli) & Company | 85 | Positive | Eli Lilly & Company (LLY) is a well-established pharmaceutical company with a strong track record in the market. The company has a market capitalization of $719 billion, indicating its significant size and stability. LLY's stock price has seen a year-to-date increase of 24.42%, despite market volatility. The stock is currently trading at a higher level compared to its 200-day average, indicating | | 2025-01-11 17:31:48 |
ACON | Aclarion Inc | 20 | Negative | ACON is a stock traded on the NCM exchange with a last price of $0.117. The stock has a market capitalization of $1.85 million and a total of 15.77 million shares outstanding. The stock has a 52-week range of $0.100 to $3.85, with a year-to-date change of -96.27%. ACON's two-hundred-day average is $0.239, while its fifty-day average is $0.163. The stock has a ten-day average volume of 37.30 million shares and a three-month average volume of 6.67 million shares. Overall, the stock has experienced significant price decline over the past year and its trading volume is relatively low. Therefore, the sentiment towards ACON is | | 2025-01-11 15:16:33 |
AA | Alcoa Corp | 80 | Positive | Alcoa Corp (AA) is a publicly traded company in the NYSE exchange. The stock has a market capitalization of $9.28 billion, with 258 million shares outstanding. The stock's last price was $35.91 with a previous close of $35.86. The year change of the stock is 19.58%, indicating a | | 2025-01-11 15:12:55 |
VRTX | Vertex Pharmaceuticals Inc | 60 | Negative | Vertex Pharmaceuticals Inc (VRTX) is a US-based biotechnology company specializing in the development and commercialization of therapies for serious diseases. VRTX stock has a market cap of $106.13 billion, indicating its significance in the healthcare sector. The stock has experienced a decline in the year, with a year change of -0.055. However, it is important to note that the stock's year high of $519.88 and year low of $377.85 indicate some volatility. The fifty-day and two hundred-day average prices are $453.00 and $457.27, respectively. The stock's day high of $413.52 and day low of $405.17 suggest stability in the short term. With a regular market previous close of $412.11 and last price of $409.56, the stock shows a slightly | | 2025-01-11 15:04:41 |
INTC | Intel Corp | 35 | Negative | Intel Corp (INTC) is a technology company that designs and manufactures semiconductor chips for a wide range of products. The company's stock has experienced a significant decline over the past year, with a year change of -0.59%. This decline can be attributed to several factors, including the impact of the COVID-19 pandemic on global demand for technology products and increasing competition in the semiconductor industry. The company's financial indicators show a market cap of $82.59 billion, indicating a large and established company. However, the low day high and day low suggest that the stock has been trading within a narrow range recently. The 50-day moving average of $22.15 indicates a declining trend in the stock price. Considering these factors, it is difficult to provide a | | 2025-01-11 12:10:23 |
ACCD | Accolade Inc | 75 | Positive | ACCD, or Accolade Inc., is a company that provides personalized healthcare assistance and support services to individuals. The company's stock has been performing moderately well in recent times, with a year change of -0.53. The stock's year high is $15.21, while the year low is $3.08. ACCD's current market cap stands at approximately $557.87 million. Looking at the key financial indicators, ACCD's day high and day low are $6.88 and $6.83 respectively. The fifty-day average is $3.58, while the two-hundred-day average is $5.08. With a last price of $6.83 and a trading volume of 11,236,578, the stock seems to be experiencing significant interest from investors. Based on the provided data, ACCD appears to be a promising investment opportunity. The stock has shown | | 2025-01-10 21:56:52 |
IONQ | IonQ Inc | 75 | Positive | IONQ is a publicly traded company listed on the New York Stock Exchange (NYSE) under the ticker symbol IONQ. The company operates in the quantum computing sector, which is a rapidly growing and lucrative industry. Quantum computing has the potential to revolutionize various fields, including finance, artificial intelligence, and drug discovery. IONQ has shown solid growth in its stock price, with a year-to-date change of 1.62 and a year high of 54.74. Currently, the stock is trading slightly above the fifty-day average. It has a market capitalization of $6.99 billion. With a three-month average volume of 28,445,909 shares, there is a decent level of liquidity for investors. Considering the | | 2025-01-10 21:56:21 |
ANET | Arista Networks Inc | 85 | Positive | Arista Networks Inc (ANET) is a technology company that specializes in the design and manufacture of high-performance networking solutions. The company has shown strong financial performance over the past year, with a year change of 83.54% and a market cap of $144.80 billion. ANET's stock price has also been trending upwards, with a year high of $120.28 and a current price of $114.94. The stock's fifty-day average of $105.21 indicates stability and suggests a potential for further growth. ANET has a strong position in the market and has consistently delivered | | 2025-01-10 18:36:32 |
FTSM | First Trust Enhanced Short Maturity ETF | 80 | Positive | The First Trust Enhanced Short Maturity ETF (FTSM) is a fixed-income ETF that aims to provide investors with a higher yield than traditional money market funds while maintaining a low duration. With a year high of $60.16 and a year low of $59.54, FTSM has shown relatively stable performance. Its year change is | | 2025-01-10 17:12:18 |